Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Med.

Sec. Pulmonary Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1648439

This article is part of the Research TopicComplex Interplay Between Lung Diseases and Multisystem Disorders: Pathogenesis, management, and OutcomeView all articles

Case report: A rare presentation of vascular Ehlers-Danlos syndrome with a massive hemothorax and a chest wall hematoma

Provisionally accepted
BEISI  HANBEISI HAN1,2Su  LiSu Li3Yutian  YeYutian Ye1Xiaoyu  LuXiaoyu Lu1Heng  ZhangHeng Zhang1*
  • 1(the Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China
  • 2Southern University of Science and Technology School of Medicine, Shenzhen, China
  • 3(the Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Department of Radiation Oncology, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China

The final, formatted version of the article will be published soon.

Background: Vascular Ehlers-Danlos syndrome (vEDS) is a rare but life-threatening subtype of the Ehlers-Danlos syndromes (EDS), a group of inherited connective tissue disorders with significant clinical and genetic heterogeneity. vEDS is mainly caused by mutations in the COL3A1 gene, leading to type III collagen abnormalities. vEDS is characterized by increased vascular fragility and predisposition to serious complications such as arterial rupture and gastrointestinal perforation. However, vEDS cases with hemothorax as the primary manifestation are extremely rare and are easily misdiagnosed or underdiagnosed.We report a 28-year-old man who was admitted to the hospital with a sudden onset of right-sided chest and back pain. Imaging examinations and thoracentesis revealed a massive right-sided hemothorax and a right posterior chest wall hematoma. The patient had a medical history of two episodes of spontaneous pneumothorax, as well as arterial aneurysms and dissections, along with a family history of major arterial rupture. After admission, his hemoglobin level progressively declined, which stabilized following right intercostal artery embolization. Genetic testing ultimately identified a heterozygous COL3A1 mutation, confirming the diagnosis of vEDS.In this case, the patient presented with a massive right-sided hemothorax and a large chest wall hematoma without any obvious precipitating factors, in the absence of other typical clinical manifestations of vEDS, such as gastrointestinal perforation, which increased the diagnostic challenge. Possible pathogenic mechanisms include type III collagen abnormalities leading to increased fragility of the subpleural vessels, triggering vascular rupture. Clinically, young patients with recurrent hemothorax or multiple arterial lesions should be kept on high alert for early genetic testing to clarify the diagnosis and optimize management. This case helps to raise awareness of the heterogeneous clinical manifestations of vEDS and to avoid misdiagnosis and underdiagnosis.

Keywords: Vascular Ehlers-Danlos syndrome, Hemothorax, Chest wall hematoma, COL3A1, rare disease

Received: 17 Jun 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 HAN, Li, Ye, Lu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Heng Zhang, (the Second Clinical Medical College, Jinan University; the First Affiliated Hospital, Southern University of Science and Technology), Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.